Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
5
×
boston blog main
5
×
boston top stories
life sciences
national blog main
startups
5
×
boston
national top stories
new york blog main
new york top stories
cancer
chemotherapy
clinical trials
deals
investing
san francisco blog main
san francisco top stories
third rock ventures
venture capital
20/20 healthcare partners
abalos therapeutics
acetonid
achillion pharmaceuticals
adeno-associated virus
aglios therapeutics
alexion pharmaceuticals
amgen ventures
amy peterson
amyotrophic lateral sclerosis
anthony despasqua
antisense oligonucleotide
aresenalbio
armo biosciences
asklepios biopharmaceutical
azacitidine
azitra
benzodiazepines
beta-thalassemia
biogen
blackstone group
What
drugs
5
×
new
medicines
aims
develop
neuro
research
therapeutics
adding
ago
aiming
approach
associated
backed
bails
balance
based
bio
biotech
brand
bridgebio
build
called
capital
car
cause
ceo
companies
debuts
decibel
developing
device
dialysis
disease
diseases
emerged
emerges
enclear
epigenetic
epigenetics
Language
unset
5
×
Current search:
startups
×
unset
×
drugs
×
biotech
×
" boston blog main "
×
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
EnClear Therapies Nets $10M to Test Neuro Disease ‘Dialysis’ Device
@xconomy.com
4 years ago
Decibel Therapeutics Strikes a Balance, Adding Regenerative Med Focus
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further